“Face Lifting” of the Newborn Chest-Surfactant and Extracorporeal Membrane Oxygenation

  • B. Newman
Conference paper
Part of the Syllabus book series (SYLLABUS)


Important recent advances have been made in the management of newborn infants with respiratory distress. Few therapeutic maneuvers have had a greater impact than surfactant and extracorporeal membrane oxygenation (ECMO). Surfactant is a relatively inexpensive drug, administered quite easily through an endotracheal tube, and has had its greatest impact on the premature infant population in whom ECMO is usually contraindicated. Conversely, ECMO is a highly advanced, expensive, time and staff intensive, technically demanding procedure used mostly in full-term babies.


Patent Ductus Arteriosus Extracorporeal Membrane Oxygenation Congenital Diaphragmatic Hernia Bronchopulmonary Dysplasia Hyaline Membrane Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Long WA, Guangbin Z, Henry GW (1996) Pharmacologic adjuncts IL exogenous surfactants. In: Goldsmith JP, Karotkin EH (eds) Assisted ventilation of the neonate, 3rd edn. WB Saunders, Philadelphia. pp 305–325Google Scholar
  2. 2.
    Avery ME, Mead J (1959) Surface active properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 17: 517–523Google Scholar
  3. 3.
    Chu J, Clements JA, Cotton EK. et al. (1967) Neonatal pul-monary ischemia. Part 1: clinical and physiological studies. Pediatrics 40: 709–782PubMedGoogle Scholar
  4. 4.
    Robillard E, Alaire Y, Dagenais-Perusse P, et al. (1964) Microaerosol administration of synthectic beta-gamma-dipalmitoyl-L-alpha-lecithin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 90: 55–57PubMedGoogle Scholar
  5. 5.
    Hawgood S, Clements JA (1990) Surfactant and its apoproteins. J Clin Invest 86: 1PubMedCrossRefGoogle Scholar
  6. 6.
    Soll RF (1997) Surfactant therapy in the USA: trials and current routines. Biol Neonate 71 (Suppl 1): 1–7PubMedGoogle Scholar
  7. 7.
    Fujiwara T, Chida S, Watabe Y, et al. (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1: 55–59PubMedCrossRefGoogle Scholar
  8. 8.
    Hennes HM, Lee MB, Rimm AA, Shapiro DL (1991) Surfactant replacement therapy in respiratory distress syndrome. AJDC 145: 102–104PubMedGoogle Scholar
  9. 9.
    Dunn MS, Shennan AT, Possmayer F (1990) Single-versus multiple-dose surfactant replacement therapy in neonates of 30–36 weeks’ gestation with respiratory distress syndrome. Pediatrics 86: 564–571PubMedGoogle Scholar
  10. 10.
    Phibbs RH, Ballard RA, Clements JA, Heilbron DC, Phibbs CS. Schlueter MA, et al. (1991) Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of Hyaline membrane disease. Pediatrics 88: 1–9PubMedGoogle Scholar
  11. 11.
    Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328: 861–868PubMedCrossRefGoogle Scholar
  12. 12.
    McColley SA (1998) Bronchopulmonary dysplasia. Impact of surfactant replacement therapy. Pediatr Clin North Am 45: 573–585PubMedCrossRefGoogle Scholar
  13. 13.
    Kattwinkel J (1998) Surfactant: evolving issues. Clin Perinatol 25: 17–32PubMedGoogle Scholar
  14. 14.
    Soll RF (1996) Appropriate surfactant usage in 1996. Eur J Pediatr 155 (Suppl 2): 8–13CrossRefGoogle Scholar
  15. 15.
    Morley CJ (1997) Systematic review of prophylactic vs rescue surfactant. Arch Dis Child 77: F70–F74Google Scholar
  16. 16.
    Schimmel MS (1995) Respiratory distress syndrome: therapeutic aspects. Pediatr Radiol 25: 641–642PubMedCrossRefGoogle Scholar
  17. 17.
    Dinger J, Schwarze R, Rupprecht E (1997) Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome. Pediatr Radiol 27: 26–31PubMedCrossRefGoogle Scholar
  18. 18.
    Skinner JR (1997) The effects of surfactant on haemodynamics in hyaline membrane disease. Arch Dis Child Fetal Neonatal Ed 76: F67–F69PubMedCrossRefGoogle Scholar
  19. 19.
    Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, et al. (1998) Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 132: 40–47PubMedCrossRefGoogle Scholar
  20. 20.
    Cleveland RH (1995) A radiologic update on medical diseases of the newborn chest. Pediatr Radiol 25: 631–637PubMedCrossRefGoogle Scholar
  21. 21.
    Dimitriou G, Greenough A, Griffin FJ, Karani J (1995) The appearance of “early” chest radiographs and the response to surfactant replacement therapy. Br J Radiol 68: 1177–1180PubMedCrossRefGoogle Scholar
  22. 22.
    Swischuk LE, Shetty BP, John SD (1996) The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems? Pediatr Radiol 26: 508–511PubMedCrossRefGoogle Scholar
  23. 23.
    Soll RF (1998) Surfactant treatment of the very preterm infant. Biol Neonate 74 (Suppl 1): 35–42PubMedCrossRefGoogle Scholar
  24. 24.
    Clyman RI, Jobe A, Heymann M, Ikegami M, Roman C, Payne B, et al. (1982) Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 100: 101–107PubMedCrossRefGoogle Scholar
  25. 25.
    Wood BP (1993) The newborn chest. Radiol Clin North Am 31: 667–676PubMedGoogle Scholar
  26. 26.
    Hamvas A, Nogee LM, Mallory GB Jr., Spray TL, Huddleston CB, August A, et al. (1997) Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130: 231–239PubMedCrossRefGoogle Scholar
  27. 27.
    Goetzman BW. Milstein JM (1996) Pharmacologic adjuncts I. In: Goldsmith JP. Karotkin EH (eds) Assisted ventilation of the neonate. WB Saunders, Philadelphia, pp 296–300Google Scholar
  28. 28.
    Northway WH (1992) Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 89: 969–973PubMedGoogle Scholar
  29. 29.
    Kanto WP Jr, Bunyapen C (1998) Extracorporeal membrane oxygenation. Controversies in selection of patients and management. Clin Perinatol 25: 123–135PubMedGoogle Scholar
  30. 30.
    Langer JC (1998) Congenital diaphragmatic hernia. Chest Surg Clin N Am 8: 295–314PubMedGoogle Scholar
  31. 31.
    Stillerman LR, Gunn SB, Hart JC, Engle WA (1997) Effects of exogenous surfactant on neonates supported by extracorporeal membrane oxygenation. J Perinatol 17: 262–265PubMedGoogle Scholar
  32. 32.
    Torosian MB, Statter MB, Arensman RM (1996) Extracor poreal membrane oxygenation. In: Goldsmith JP, Karotkin EH, (eds) Assisted ventilation of the neonate, 3rd edn. WB Saunders, Philadelphia, pp 241–256Google Scholar
  33. 33.
    Bartlett RH, Gazzaniga AB, Jefferies MR, et al. (1976) Extracorporeal membrane oxygenation ( ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22: 80–93PubMedGoogle Scholar
  34. 34.
    Fox WW, Dura S (1983) Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 103: 505–514CrossRefGoogle Scholar
  35. 35.
    Bartlett RH, Toomasian J, Roloff D, et al. (1986) Extracorporeal membrane oxygenation in neonatal respiratory failure: 100 cases. Ann Surg 204: 236–245PubMedCrossRefGoogle Scholar
  36. 36.
    Short BL, Miller MK, Anderson KD (1987) Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol 14: 737–748PubMedGoogle Scholar
  37. 37.
    Redmond CR, Graves ED, Falterman KW, et al. (1987) Extracorporeal membrane oxygenation for respiratory and cardiac failure in infants and children. J Thorac Cardiovasc Surg 93: 199–204PubMedGoogle Scholar
  38. 38.
    Swischuk LE (1997) Imaging of the newborn, infant, and young child, 4th edn. Williams & Wilkins, Baltimore, pp 105–107Google Scholar
  39. 39.
    Knight GR, Dudell GG, Evans ML, Grimm PS (1996) A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure. Crit Care Med 24: 1678–1683PubMedCrossRefGoogle Scholar
  40. 40.
    Cornish JD, Heiss KF, Clark RH, et al. (1993) Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. J Pediatr 122: 105–109PubMedCrossRefGoogle Scholar
  41. 41.
    DeAngelis GA, Mitchell DG, Merton DA, Wolfson PJ, Desai HJ, Desai SA, et al. (1992) Right common carotid artery reconstruction in neonates after extracorporeal membrane oxygenation: color Doppler imaging. Radiology 182: 521–525PubMedGoogle Scholar
  42. 42.
    Gross GW, Cullen J, Kornhauser MS, Wolfson PJ (1992) Thoracic complications of extracorporeal membrane oxygenation: findings on chest radiographs and sonograms. AJR 158: 353–358PubMedGoogle Scholar
  43. 43.
    Taylor GA, Short BL, Kriesmer P (1986) Extracorporeal membrane oxygenation: radiographic appearance of the neonatal chest. AJR 146: 1257–1260PubMedGoogle Scholar
  44. 44.
    Kelly RE, Phillips JD, Foglia RP, et al. (1991) Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg 26: 1016–1022PubMedCrossRefGoogle Scholar
  45. 45.
    Zwischenberger JB, Nguyen TT, Upp JR Jr, et al. (1994) Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 107: 838–848PubMedGoogle Scholar
  46. 46.
    Weber TR, Kountzman B (1996) The effects of venous occlusion on cerebral blood flow characteristics during ECMO. J Pediatr Surg 31: 1124–1127PubMedCrossRefGoogle Scholar
  47. 47.
    Kornhauser MS, Cullen JA, Baumgart S. et al. (1994) Risk factors for bronchopulmonary dysplasia after extracorporeal membrane oxygenation. Arch Pediatr Adolesc Med 148: 820–825CrossRefGoogle Scholar
  48. 48.
    Graziani LJ. Gringlas M, Baumgart S (1997) Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol 24: 655–675PubMedGoogle Scholar
  49. 49.
    Bulas DI, Taylor GA, O’Donnell RM, Short BL, Fitz CR, Vezina G (1996) Intracranial abnormalities in infants treated with extracorporeal membrane oxygenation: update on sonographic and CT findings. AJNR 17: 287–294PubMedGoogle Scholar
  50. 50.
    Hofkosh D, Thompson AE, Nozza RJ, et al. (1991) Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics 87: 549–555PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • B. Newman
    • 1
  1. 1.Department of RadiologyChildren’s Hospital of PittsburghPittsburghUSA

Personalised recommendations